These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 32511315)

  • 1. Activation of the SARS-CoV-2 receptor
    Hennighausen L; Lee HK
    bioRxiv; 2020 May; ():. PubMed ID: 32511315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the SARS-CoV-2 Receptor Ace2 through JAK/STAT-Dependent Enhancers during Pregnancy.
    Hennighausen L; Lee HK
    Cell Rep; 2020 Sep; 32(13):108199. PubMed ID: 32966801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the SARS-CoV-2 receptor
    Hennighausen L; Lee HK
    SSRN; 2020 May; ():3601827. PubMed ID: 32714116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.
    Sajuthi SP; DeFord P; Li Y; Jackson ND; Montgomery MT; Everman JL; Rios CL; Pruesse E; Nolin JD; Plender EG; Wechsler ME; Mak ACY; Eng C; Salazar S; Medina V; Wohlford EM; Huntsman S; Nickerson DA; Germer S; Zody MC; Abecasis G; Kang HM; Rice KM; Kumar R; Oh S; Rodriguez-Santana J; Burchard EG; Seibold MA
    Nat Commun; 2020 Oct; 11(1):5139. PubMed ID: 33046696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19.
    Luo W; Li YX; Jiang LJ; Chen Q; Wang T; Ye DW
    Trends Pharmacol Sci; 2020 Aug; 41(8):531-543. PubMed ID: 32580895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathway.
    Chen DY; Khan N; Close BJ; Goel RK; Blum B; Tavares AH; Kenney D; Conway HL; Ewoldt JK; Kapell S; Chitalia VC; Crossland NA; Chen CS; Kotton DN; Baker SC; Connor JH; Douam F; Emili A; Saeed M
    bioRxiv; 2020 Oct; ():. PubMed ID: 33140044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covid-19: Perspectives on Innate Immune Evasion.
    Taefehshokr N; Taefehshokr S; Hemmat N; Heit B
    Front Immunol; 2020; 11():580641. PubMed ID: 33101306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of androgens in COVID-19.
    Moradi F; Enjezab B; Ghadiri-Anari A
    Diabetes Metab Syndr; 2020; 14(6):2003-2006. PubMed ID: 33091758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An aberrant STAT pathway is central to COVID-19.
    Matsuyama T; Kubli SP; Yoshinaga SK; Pfeffer K; Mak TW
    Cell Death Differ; 2020 Dec; 27(12):3209-3225. PubMed ID: 33037393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evasion of Type I Interferon by SARS-CoV-2.
    Xia H; Cao Z; Xie X; Zhang X; Chen JY; Wang H; Menachery VD; Rajsbaum R; Shi PY
    Cell Rep; 2020 Oct; 33(1):108234. PubMed ID: 32979938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell RNA-seq Identifies Cell Subsets in Human Placenta That Highly Expresses Factors Driving Pathogenesis of SARS-CoV-2.
    Ashary N; Bhide A; Chakraborty P; Colaco S; Mishra A; Chhabria K; Jolly MK; Modi D
    Front Cell Dev Biol; 2020; 8():783. PubMed ID: 32974340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract.
    Ortiz ME; Thurman A; Pezzulo AA; Leidinger MR; Klesney-Tait JA; Karp PH; Tan P; Wohlford-Lenane C; McCray PB; Meyerholz DK
    EBioMedicine; 2020 Oct; 60():102976. PubMed ID: 32971472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting TMPRSS2 in SARS-CoV-2 Infection.
    Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
    Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19.
    Ramaiah MJ
    Gene Rep; 2020 Sep; 20():100765. PubMed ID: 32835132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between SARS-CoV-2 and the type I interferon response.
    Sa Ribero M; Jouvenet N; Dreux M; Nisole S
    PLoS Pathog; 2020 Jul; 16(7):e1008737. PubMed ID: 32726355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies.
    Ragia G; Manolopoulos VG
    Eur J Clin Pharmacol; 2020 Dec; 76(12):1623-1630. PubMed ID: 32696234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic mechanisms regulating COVID-19 infection.
    Chlamydas S; Papavassiliou AG; Piperi C
    Epigenetics; 2021 Mar; 16(3):263-270. PubMed ID: 32686577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.
    Mjaess G; Karam A; Aoun F; Albisinni S; Roumeguère T
    Prog Urol; 2020 Sep; 30(10):484-487. PubMed ID: 32620366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.